Allurion Technologies Inc (ALUR) ニュース

Form 4 - Statement of changes in beneficial ownership of securities

Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey

New data demonstrates 80% sustained weight loss at three years with the Allurion Program and initial positive outcomes of a novel, generative...

Allurion Announces Preliminary First Quarter 2024 Results

Generated quarter-over-quarter revenue growth and continued growth in procedural volume, while substantially reducing cash burn Company to report...

Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments

Simplifies capital structure through prepayment of existing term loan Reduces annual interest expense, providing increased near-term cash flow...

Allurion Expands Virtual Care Suite to the United States

Virtual Care Suite (VCS) is now available to license in the United States for providers offering GLP-1 and other anti-obesity medication therapy...

Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion”), a company dedicated to ending obesity, today reported financial results for the fourth...

Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the 34th Annual...

Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the appointment of its newest board member and...

Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will report financial results for the...

Allurion to Participate in Cowen’s 44th Annual Health Care Conference

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the 44th Annual...

Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the BTIG...

Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies

Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Brendan Gibbons as its new...

Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss

Allurion Program is the latest innovation in the NHS’s war against obesity Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to...

World first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss

Allurion Program is the latest innovation in the NHS’s war against obesity Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to...

Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships

Company inks deals with Lazeo and Transform, two of Europe’s largest aesthetic and weight loss groups Allurion Technologies, Inc. (NYSE:ALUR), a...